Richie R E, Niblack G D, Johnson H K, Green W F, MacDonell R C, Turner B I, Tallent M B
Ann Surg. 1983 Jun;197(6):672-7. doi: 10.1097/00000658-198306000-00005.
This study is a multifactorial analysis of 389 transplants performed from June 1977 to December 1981. Analysis of the effects of transfusions antilymphocyte serum (ALS), histocompatibility testing, gender, and patient risk factors (presence of concomitant disease, greater than 50 years of age, etc.) was done. Two-hundred fifty-three patients received cadaver kidneys and 136 patients obtained kidneys from a relative. Two-hundred eighty-three (73%) patients received blood transfusions prior to transplantation. Our data showed that recipients receiving transfusions prior to transplantation had a significantly higher graft survival than those who were not transfused in both cadaveric and related graft recipients. Two-hundred twenty-one (56%) patients received ALS following the transplant. This group had a 15% higher graft survival than a comparable group. Analysis of histocompatibility testing data shows approximately 5% higher functional graft survival between each match grade. Surprisingly, female patients receiving kidneys from living related donors had a 16% higher graft survival than male patients. In cadaver recipients female patients had a 10% higher patient survival as compared to male patients. The risk factor status of recipients affected not only graft survival but patient survival, which probably is due to the consequences of immunotherapy. The authors' conclusion is that the above mentioned factors may be additive in nature. Further, multivariable analysis is necessary in order to correctly transplant data.
本研究是对1977年6月至1981年12月期间进行的389例移植手术的多因素分析。分析了输血、抗淋巴细胞血清(ALS)、组织相容性检测、性别以及患者风险因素(合并疾病的存在、年龄大于50岁等)的影响。253例患者接受了尸体肾移植,136例患者从亲属处获得肾脏。283例(73%)患者在移植前接受了输血。我们的数据显示,在尸体肾移植和亲属供肾移植受者中,移植前接受输血的受者的移植物存活率显著高于未输血的受者。221例(56%)患者在移植后接受了ALS治疗。该组的移植物存活率比对照组高15%。组织相容性检测数据分析显示,每个匹配等级之间的功能性移植物存活率大约高5%。令人惊讶的是,接受活体亲属供肾的女性患者的移植物存活率比男性患者高16%。在尸体肾移植受者中,女性患者的患者存活率比男性患者高10%。受者的风险因素状态不仅影响移植物存活率,还影响患者存活率,这可能是由于免疫治疗的结果。作者的结论是,上述因素在性质上可能具有累加性。此外,为了正确分析移植数据,有必要进行多变量分析。